Crescent Biopharma, Inc.
CBIO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001253689
In the last 90 days, Crescent Biopharma, Inc. insiders filed 1 open-market purchase and 7 sales; 82 institutions reported holding it in 13F filings for Q2 2026, worth $532.6M in total; no superinvestor holds it.
13F holders, Q4 2021
Institutional positions in Crescent Biopharma, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 47
- −1 vs. Q3 2021
- Shares held
- 29.7M
- +34.1K (+0.1%) vs. Q3 2021
- Total value
- $42.7M
- −$22.2M (−34.2%) vs. Q3 2021
- New holders
- 5
- 17 more added
- Sold out
- 6
- 14 more reduced
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CBIO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 82 | $532.6M |
| Q1 2026 | 63 | $476.6M |
| Q4 2025 | 58 | $285.9M |
| Q3 2025 | 41 | $134.6M |
| Q2 2025 | 30 | $173.5M |
| Q1 2025 | 35 | $6.46M |
| Q4 2024 | 41 | $7.56M |
| Q3 2024 | 36 | $3.00M |
| Q2 2024 | 35 | $7.20M |
| Q1 2024 | 69 | $110.5M |
| Q4 2023 | 58 | $82.8M |
| Q3 2023 | 49 | $52.1M |
| Q2 2023 | 55 | $61.9M |
| Q1 2023 | 54 | $46.6M |
| Q4 2022 | 48 | $83.3M |
| Q3 2022 | 35 | $14.3M |
| Q2 2022 | 37 | $15.8M |
| Q1 2022 | 44 | $31.2M |
| Q4 2021 | 47 | $42.7M |
| Q3 2021 | 48 | $64.9M |
| Q2 2021 | 58 | $72.5M |
| Q1 2021 | 78 | $110.4M |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Crescent Biopharma, Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Wells Fargo & Company | 254 | $0 | 0.00% | +1+0.4% | Added |
| FinTrust Capital Advisors, LLC | 245 | $0 | 0.00% | +245 | New |
| BNP Paribas Arbitrage, SA | 481 | $693 | 0.00% | −61−11.3% | Reduced |
| FMR LLC | 1,000 | $1.00K | 0.00% | +300+42.9% | Added |
| Advisor Group Holdings, Inc. | 600 | $1.00K | 0.00% | −500−45.5% | Reduced |
| Carolinas Wealth Consulting LLC | 395 | $1.00K | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 1,238 | $2.00K | 0.00% | −29,411−96.0% | Reduced |
| Hartford Financial Management Inc. | 3,500 | $5.00K | 0.00% | 00.0% | Unchanged |
| Bank Julius Baer & Co. Ltd, Zurich | 5,000 | $7.00K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 7,272 | $10.0K | 0.00% | +2,216+43.8% | Added |
| Commonwealth Equity Services, LLC | 10,000 | $14.0K | 0.00% | 00.0% | Unchanged |
| XR Securities LLC | 10,395 | $15.0K | 0.00% | +10,395 | New |
| Bank of America Corp | 11,714 | $17.0K | 0.00% | −3,089−20.9% | Reduced |
| Prentiss Smith & Co Inc | 14,000 | $20.0K | 0.01% | 00.0% | Unchanged |
| UBS Group AG | 21,054 | $30.0K | 0.00% | +21,022+65,693.8% | Added |
| Bank of New York Mellon Corp | 26,299 | $38.0K | 0.00% | 00.0% | Unchanged |
| Algert Global LLC | 26,174 | $38.0K | 0.00% | +14,630+126.7% | Added |
| ExodusPoint Capital Management, LP | 29,290 | $42.0K | 0.00% | +6,858+30.6% | Added |
| Charles Schwab Investment Management Inc | 34,903 | $51.0K | 0.00% | 00.0% | Unchanged |
| Ieq Capital, LLC | 38,363 | $55.0K | 0.00% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 38,533 | $55.0K | 0.00% | +12,158+46.1% | Added |
| Morgan Stanley | 53,155 | $76.0K | 0.00% | −14,769−21.7% | Reduced |
| Intellectus Partners, LLC | 80,500 | $116.0K | 0.03% | −42,500−34.6% | Reduced |
| Susquehanna Fundamental Investments, LLC | 90,876 | $131.0K | 0.00% | −44,841−33.0% | Reduced |
| Citadel Advisors LLC | 96,275 | $138.0K | 0.00% | +43,111+81.1% | Added |
| Northern Trust Corp | 98,487 | $142.0K | 0.00% | +621+0.6% | Added |
| Simplex Trading, LLC | 99,302 | $142.0K | 0.00% | +99,302 | New |
| Eversept Partners, LP | 100,000 | $144.0K | 0.01% | +100,000 | New |
| Connor, Clark & Lunn Investment Management Ltd. | 119,395 | $172.0K | 0.00% | +7,097+6.3% | Added |
| State Street Corp | 144,265 | $208.0K | 0.00% | 00.0% | Unchanged |
| Gsa Capital Partners LLP | 146,078 | $210.0K | 0.03% | +146,078 | New |
| Bridgeway Capital Management, LLC | 155,400 | $224.0K | 0.00% | −13,300−7.9% | Reduced |
| Franklin Resources Inc | 160,307 | $231.0K | 0.00% | −393−0.2% | Reduced |
| Susquehanna International Group, LLP | 265,208 | $382.0K | 0.00% | +184,857+230.1% | Added |
| D. E. Shaw & Co., Inc. | 267,871 | $385.0K | 0.00% | −48,915−15.4% | Reduced |
| Federated Hermes, Inc. | 345,452 | $497.0K | 0.00% | +829+0.2% | Added |
| Geode Capital Management, LLC | 365,106 | $525.0K | 0.00% | −1,195−0.3% | Reduced |
| Dimensional Fund Advisors LP | 564,388 | $813.0K | 0.00% | −340,240−37.6% | Reduced |
| Renaissance Technologies LLC | 601,300 | $866.0K | 0.00% | +5,200+0.9% | Added |
| Two Sigma Investments, LP | 610,262 | $879.0K | 0.00% | +111,732+22.4% | Added |
| Two Sigma Advisers, LP | 654,800 | $943.0K | 0.00% | +33,800+5.4% | Added |
| Millennium Management LLC | 691,713 | $996.0K | 0.00% | +243,703+54.4% | Added |
| BlackRock Inc. | 872,858 | $1.26M | 0.00% | −2,293−0.3% | Reduced |
| Acadian Asset Management LLC | 1,951,086 | $2.81M | 0.01% | +64,999+3.4% | Added |
| Vanguard Group Inc | 2,238,553 | $3.22M | 0.00% | −21,461−0.9% | Reduced |
| NEA Management Company, LLC | 9,089,041 | $13.1M | 0.26% | 00.0% | Unchanged |
| BVF Inc | 9,544,262 | $13.7M | 0.50% | 00.0% | Unchanged |
| Jacobs Levy Equity Management, Inc | 0 | $0 | 0.00% | −365,013−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −54,147−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −51,284−100.0% | Sold out |
| Advisory Services Network, LLC | 0 | $0 | 0.00% | −31,800−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −4,819−100.0% | Sold out |
| Lindbrook Capital, LLC | 0 | $0 | 0.00% | −5,000−100.0% | Sold out |